This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Walgreens (WBA) Expands Access to COVID-19 Test With LabCorp
by Zacks Equity Research
Walgreens (WBA) will enable more communities to access reliable, convenient testing services as and when required with the addition of Pixel by LabCorp COVID-19 at-home collection kit.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $46.72, moving +1.24% from the previous trading session.
Walgreens Boots Alliance (WBA) Stock Moves -0.72%: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $45.46, marking a -0.72% move from the previous day.
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $48.30, marking a +1.98% move from the previous day.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $49.99 in the latest trading session, marking a +0.4% move from the prior day.
Walgreens Boots Alliance (WBA) Stock Moves -1.81%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $49.50 in the latest trading session, marking a -1.81% move from the prior day.
Walgreens (WBA), Village MD Plan to Expand Into Arizona
by Zacks Equity Research
Walgreens (WBA) and VillageMD to improve access to overall care for patients with chronic conditions by opening eight new Village Medical at Walgreens primary care practices in the Tucson area.
Here's Why You Should Hold on to Walgreens Boots (WBA) for Now
by Zacks Equity Research
Investors are optimistic about Walgreens Boots' (WBA) robust growth in the International segment and strong first-quarter fiscal 2022 results.
Walgreens Boots (WBA) Q1 Earnings Top Estimates, 2022 View Up
by Zacks Equity Research
Walgreens Boots' (WBA) revenues increased year over year in the fiscal first quarter, driven by COVID-19 vaccinations and testing.
Walgreens Boots Alliance (WBA) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 24.44% and 2.71%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots (WBA) Gains From New Pacts, Faces Margin Woes
by Zacks Equity Research
Of late, increased reimbursement pressure and generic drug cost inflation have been hampering Walgreens Boots' (WBA) margins significantly.
2022: The Year We Exit The Pandemic & The Roaring 20s Commence
by Daniel Laboe
2022 will be a stock pickers market with opportunities arising from prudent equity research
Walgreens (WBA) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Faster adoption of digital health and recent partnerships are expected to have contributed to Walgreens' (WBA) first-quarter performance.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $51.99, marking a -0.5% move from the previous day.
Walgreens Boots Alliance (WBA) Reports Next Week: What Awaits?
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stock Market News for Dec 30, 2021
by Zacks Equity Research
The S&P 500 and Dow closed at record highs on Wednesday as investors shed Omicron fears despite a surge in new cases and hospitalizations.
Dow, S&P Set Fresh All-Time Closing Highs
by Mark Vickery
Value plays look to have dried up during the past few sessions that account for the front end of the Santa Claus Rally.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $50.48 in the latest trading session, marking a +0.14% move from the prior day.
Rite Aid (RAD) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Rite Aid (RAD) delivered earnings and revenue surprises of 183.33% and 0.83%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Stock Moves -0.04%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $48.83 in the latest trading session, marking a -0.04% move from the prior day.
Walgreens (WBA), Village MD Plan to Expand Into San Antonio
by Zacks Equity Research
Walgreens (WBA) and VillageMD to improve access to overall care for patients with chronic conditions by opening nine new Village Medical at Walgreens primary care practices in San Antonio.
Walgreens Boots Alliance (WBA) Stock Moves -0.73%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $49.14, moving -0.73% from the previous trading session.
GameStop (GME) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
GameStop (GME) delivered earnings and revenue surprises of -531.82% and 0.49%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $48.23 in the latest trading session, marking a -0.14% move from the prior day.
Walgreens Boots (WBA) Faces Margin Pressure, Solvency Issue
by Zacks Equity Research
Of late, increased reimbursement pressure and generic drug cost inflation have been hampering Walgreens Boots' (WBA) margin significantly.